| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-05 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |